ORKA-001 EVERLAST-A 16-week data showed 63.5% PASI 100 rate and a favorable tolerability profile, with longer-term data expected in 2H ...
Shawn Mendes was spotted with a bloody injury in Beverly Hills, California, on Tuesday, as seen in gruesome photos obtained by Page Six. The singer, 27, held a stained towel over his left hand as he ...
USA: A new study has highlighted promising results for a targeted therapy in managing generalized pustular psoriasis (GPP), a ...
I spent every night tearing my skin apart, but specialists refused to listen and insisted it was dry skin or an allergic ...
AbbVie's Skyrizi is one of its most important growth drivers. This drug could face competition from a newer medicine under ...
In this video, Melinda J. Gooderham, MD, MSc, FRCPC, FAAD, discusses two phase 3 trials presented at the American Academy of ...
MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where ...
Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...
Among patients with psoriasis affecting special anatomical sites, IL-17 inhibitors are associated with significant improvements in PASI 75 and 90.
Tildrakizumab delivers sustained improvements in psoriasis severity and patient-reported outcomes, according to a recent Italian study.
The National Psoriasis Foundation has issued a statement that endorses consideration of adjunctive GLP-1 receptor agonists in ...
The National Psoriasis Foundation (NPF) will host its third annual Houston Soirée on Saturday, September 26, 2026, at the C. Baldwin Hotel in downtown Houston. The signature fundraising event will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results